Call For Papers
The ICRAAS aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Rheumatology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Autoantibodies in rheumatic disease diagnosis
- Role of autoantibodies in disease progression
- Novel autoantibody testing methodologies
- Clinical implications of autoantibody profiles
- Autoantibodies and treatment responses
- Genetic factors influencing autoantibody production
- Autoantibody research in systemic diseases
- Impact of environmental factors on autoimmunity
- Autoantibodies and comorbid conditions
- Therapeutic targets in autoantibody research
- Longitudinal studies on autoantibody development
- Autoantibodies in pediatric rheumatology
- Ethical considerations in autoantibody research
- Autoantibody prevalence in different populations
- Role of autoantibodies in personalized medicine
- Clinical trials involving autoantibody therapies
- Autoantibody profiles in inflammatory arthritis
- Impact of lifestyle on autoantibody levels
- Future directions in autoantibody research
- Collaboration between researchers and clinicians
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.